Tag: e-mail

SAN DIEGO, July 08, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”), have until Monday, August 11, 2025 to seek appointment as lead plaintiff of the Rocket Pharmaceuticals class action lawsuit. Captioned Ho v. Rocket Pharmaceuticals, Inc., No. 25-cv-10049 (D.N.J.), the Rocket Pharmaceuticals class action lawsuit charges Rocket Pharmaceuticals as well as one of Rocket Pharmaceuticals’ top executives with violations of the Securities Exchange Act of 1934.

Grupi 2025. aasta II kvartali auditeerimata konsolideeritud müügitulu kahanes 2024. aasta sama perioodiga võrreldes 9% ja oli kokku €3 440 tuhat (II kv 2024: €3 782 tuhat). 2025. aasta I poolaasta auditeerimata konsolideeritud müügitulu vähenes eelmise aastaga võrreldes samuti 9% ja oli kokku €7 120 tuhat (2024. a I pa: €7 809 tuhat).